Quick answer
Even though Basic Cell therapy mainly uses the patient's own cells, it still carries the baseline risks of any injection procedure — swelling, bruising, injection-site pain, and in some cases infection risk if not performed to proper standards. South Korea regulates cell therapy through the Ministry of Food and Drug Safety (MFDS) and dedicated cell and gene therapy law. Patients should ask the clinic directly what approval or oversight category their specific programme falls under, rather than assuming.
